Literature DB >> 2507747

The effect of a high protein diet on leucine and alanine turnover in acid maltase deficiency.

A M Umpleby1, P S Trend, D Chubb, J V Conaglen, C D Williams, R Hesp, I N Scobie, C M Wiles, G Spencer, P H Sönksen.   

Abstract

Leucine and alanine production rate was measured in 5 patients with acid maltase deficiency in the postabsorptive state, following 6 months on a normal diet with placebo and 6 months on an isocaloric high protein diet (16-22% protein). Whole body leucine production rate, a measure of protein degradation, expressed in terms of lean body mass was significantly greater than in five control subjects. Following the high protein diet, leucine production rate was decreased in four of the five patients but this was not statistically significant. Alanine production rate expressed in terms of lean body mass was significantly greater than in control subjects. After the high protein diet, alanine production rate and concentration were significantly decreased (p less than 0.05). There were no significant improvements in any of the clinically relevant variables measured in these patients. It is possible that a larger increase in protein intake over a longer time period may have a clinical effect.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507747      PMCID: PMC1031833          DOI: 10.1136/jnnp.52.8.954

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  31 in total

1.  [On the metabolite content and the metabolite concentration in the liver of the rat].

Authors:  H J HOHORST; F H KREUTZ; T BUECHER
Journal:  Biochem Z       Date:  1959

2.  Alpha glucosidases in white blood cells, with reference to the detection of acid alpha 1-4 glucosidase deficiency.

Authors:  J C Dreyfus; L Poënaru
Journal:  Biochem Biophys Res Commun       Date:  1978-11-29       Impact factor: 3.575

3.  Maximal static respiratory pressures in generalized neuromuscular disease.

Authors:  L F Black; R E Hyatt
Journal:  Am Rev Respir Dis       Date:  1971-05

4.  Effects of Duchenne muscular dystrophy on muscle protein synthesis.

Authors:  M J Rennie; R H Edwards; D J Millward; S L Wolman; D Halliday; D E Matthews
Journal:  Nature       Date:  1982-03-11       Impact factor: 49.962

5.  The relation of total body potassium to height, weight, and age in normal adults.

Authors:  K Boddy; P C King; R Hume; E Weyers
Journal:  J Clin Pathol       Date:  1972-06       Impact factor: 3.411

6.  Whole-body leucine and lysine metabolism: response to dietary protein intake in young men.

Authors:  K J Motil; D E Matthews; D M Bier; J F Burke; H N Munro; V R Young
Journal:  Am J Physiol       Date:  1981-06

7.  Influence of muscle wasting on oral glucose tolerance testing.

Authors:  R T Moxley; R C Griggs; G B Forbes; D Goldblatt; K Donohoe
Journal:  Clin Sci (Lond)       Date:  1983-06       Impact factor: 6.124

8.  Effects of major skeletal trauma on whole body protein turnover in man measured by L-[1,14C]-leucine.

Authors:  R H Birkhahn; C L Long; D Fitkin; J W Geiger; W S Blakemore
Journal:  Surgery       Date:  1980-08       Impact factor: 3.982

9.  Improvement of muscle function in acid maltase deficiency by high-protein therapy.

Authors:  A E Slonim; R A Coleman; M A McElligot; J Najjar; K Hirschhorn; G U Labadie; R Mrak; O B Evans; E Shipp; R Presson
Journal:  Neurology       Date:  1983-01       Impact factor: 9.910

10.  Comparative study of acid maltase deficiency. Biochemical differences between infantile, childhood, and adult types.

Authors:  C Angelini; A G Engel
Journal:  Arch Neurol       Date:  1972-04
View more
  6 in total

Review 1.  Nutrition and exercise in Pompe disease.

Authors:  Mark A Tarnopolsky; Mats I Nilsson
Journal:  Ann Transl Med       Date:  2019-07

2.  Adult-onset acid maltase deficiency with prominent bulbar involvement and ptosis.

Authors:  D Barnes; R A Hughes; G T Spencer
Journal:  J R Soc Med       Date:  1993-01       Impact factor: 5.344

3.  The effect of L-alanine therapy in a patient with adult onset glycogen storage disease type II.

Authors:  H R Mundy; J E Williams; A J Cousins; P J Lee
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

4.  Efficacy of multidisciplinary approach in the treatment of two cases of nonclassical infantile glycogenosis type II.

Authors:  B Bembi; G Ciana; C Martini; A Benettoni; A Gombacci; M Deganuto; M G Pittis
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

5.  Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice.

Authors:  Richard L Sidman; Tatyana Taksir; Jonathan Fidler; Michael Zhao; James C Dodge; Marco A Passini; Nina Raben; Beth L Thurberg; Seng H Cheng; Lamya S Shihabuddin
Journal:  J Neuropathol Exp Neurol       Date:  2008-08       Impact factor: 3.685

6.  L-alanine supplementation in Pompe disease (IOPD): a potential therapeutic implementation for patients on ERT? A case report.

Authors:  Valentina Rovelli; Juri Zuvadelli; Marta Piotto; Andrea Scopari; Alice Re Dionigi; Vittoria Ercoli; Sabrina Paci; Graziella Cefalo; Elisabetta Salvatici; Giuseppe Banderali
Journal:  Ital J Pediatr       Date:  2022-03-28       Impact factor: 2.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.